aluates Reports

$ 0.0

Automative

Global RNAi-based Biopesticides Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-15A17585

Global RNAi based Biopesticides Market Research Report 2024

BUY CHAPTERS

Global RNAi-based Biopesticides Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-15A17585

Report

October 2025

Pages:157

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bayer

Syngenta AG

Corteva, Inc.

BASF AG

JR Simplot

Greenlight Biosciences

RNAissance Ag

Pebble Labs

Renaissance BioScience

AgroSpheres

Silicon Gene

Shanghai Plant Science Biotechnology

Xiaomo Biotech

RNAi-based Biopesticides Market Size

The global RNAi-based Biopesticides market is projected to grow from US$ 135 million in 2024 to US$ 284 million by 2031, at a CAGR of 11.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

RNAi-based Biopesticides Market

RNA interference (RNAi) is a biotechnology-based approach to developing biopesticides that achieve precise and efficient pest control by targeting key genes in pests. RNAi-based biopesticides introduce specific double-stranded RNA (dsRNA) into the pest organism, disrupting gene expression and consequently inhibiting its growth, development, or survival. This method is highly selective, affecting only the targeted pest species while minimizing impacts on non-target organisms and the environment, making it an eco-friendly solution. RNAi biopesticides have shown significant potential in controlling pests like the corn borer and cotton bollworm, offering a novel tool for resistance management.

RNA interference (RNAi) technology is gaining significant attention in agriculture as an innovative biopesticide approach. These pesticides target specific pest genes, suppressing their growth or reproduction, thereby achieving precise and efficient pest control. Compared to traditional chemical pesticides, RNAi-based biopesticides have minimal impact on the environment and non-target organisms, making them more ecologically compatible. Currently, research and applications focus on controlling pests, pathogens, and plant viruses, with notable advancements in transgenic crop development and topical application techniques. However, due to the technological complexity and stringent regulatory processes, RNAi biopesticides still have limited market penetration.As agriculture increasingly demands sustainability and precision, RNAi biopesticides are seen as a key direction for the future of pesticide technology. Advances in more efficient RNA delivery mechanisms, improved molecular stability, and declining costs will further drive adoption. Additionally, stricter global pesticide regulations and heightened consumer concern for food safety will push the industry towards low-toxicity and high-selectivity products. Cross-disciplinary applications of RNAi in fields like bioinformatics, gene editing, and smart agriculture also open new opportunities for its development.Key drivers for RNAi biopesticides include policy support, growing market demand for green agriculture, and advancements in biotechnology. However, significant challenges remain, including high R&D costs, limitations in target specificity, poor RNA stability in the environment, and public concerns about genetic technologies. Moreover, varying acceptance levels and regulatory frameworks across different regions present additional hurdles to commercialization.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global RNAi-based Biopesticides market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of RNAi-based Biopesticides Market Report

Report Metric	Details
Report Name	RNAi-based Biopesticides Market
Accounted market size in 2024	US$ 135 million
Forecasted market size in 2031	US$ 284 million
CAGR	11.3%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	PIP Non-PIP
Segment by Application	Farmland Orchard Other
Production by Region	North America Europe China Japan
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Syngenta, Corteva, BASF, JR Simplot, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the RNAi-based Biopesticides study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is RNAi-based Biopesticides Market growing?

Ans: The RNAi-based Biopesticides Market witnessing a CAGR of 11.3% during the forecast period 2025-2031.

What is the RNAi-based Biopesticides Market size in 2031?

Ans: The RNAi-based Biopesticides Market size in 2031 will be US$ 284 million.

Who are the main players in the RNAi-based Biopesticides Market report?

Ans: The main players in the RNAi-based Biopesticides Market are Bayer, Syngenta, Corteva, BASF, JR Simplot, Greenlight Biosciences, RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres, Silicon Gene, Shanghai Plant Science Biotechnology, Xiaomo Biotech

What are the Application segmentation covered in the RNAi-based Biopesticides Market report?

Ans: The Applications covered in the RNAi-based Biopesticides Market report are Farmland, Orchard, Other

What are the Type segmentation covered in the RNAi-based Biopesticides Market report?

Ans: The Types covered in the RNAi-based Biopesticides Market report are PIP, Non-PIP

Recommended Reports

Biopesticides and Biologicals

RNAi and Genetic Tech

Pesticide and Pest Solutions

1 Study Coverage

1.1 Introduction to RNAi-based Biopesticides: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global RNAi-based Biopesticides Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 PIP

1.2.3 Non-PIP

1.3 Market Segmentation by Application

1.3.1 Global RNAi-based Biopesticides Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Farmland

1.3.3 Orchard

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global RNAi-based Biopesticides Revenue Estimates and Forecasts 2020-2031

2.2 Global RNAi-based Biopesticides Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global RNAi-based Biopesticides Sales Estimates and Forecasts 2020-2031

2.4 Global RNAi-based Biopesticides Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global RNAi-based Biopesticides Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global RNAi-based Biopesticides Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global RNAi-based Biopesticides Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 PIP Market Size by Manufacturers

4.5.2 Non-PIP Market Size by Manufacturers

4.6 Global RNAi-based Biopesticides Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global RNAi-based Biopesticides Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global RNAi-based Biopesticides Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global RNAi-based Biopesticides Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global RNAi-based Biopesticides Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America RNAi-based Biopesticides Sales and Revenue by Type (2020-2031)

7.4 North America RNAi-based Biopesticides Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America RNAi-based Biopesticides Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe RNAi-based Biopesticides Sales and Revenue by Type (2020-2031)

8.4 Europe RNAi-based Biopesticides Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe RNAi-based Biopesticides Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific RNAi-based Biopesticides Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific RNAi-based Biopesticides Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific RNAi-based Biopesticides Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America RNAi-based Biopesticides Sales and Revenue by Type (2020-2031)

10.4 Central and South America RNAi-based Biopesticides Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America RNAi-based Biopesticides Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa RNAi-based Biopesticides Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa RNAi-based Biopesticides Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa RNAi-based Biopesticides Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Bayer

12.1.1 Bayer Corporation Information

12.1.2 Bayer Business Overview

12.1.3 Bayer RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.1.4 Bayer RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Bayer RNAi-based Biopesticides Sales by Product in 2024

12.1.6 Bayer RNAi-based Biopesticides Sales by Application in 2024

12.1.7 Bayer RNAi-based Biopesticides Sales by Geographic Area in 2024

12.1.8 Bayer RNAi-based Biopesticides SWOT Analysis

12.1.9 Bayer Recent Developments

12.2 Syngenta

12.2.1 Syngenta Corporation Information

12.2.2 Syngenta Business Overview

12.2.3 Syngenta RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.2.4 Syngenta RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Syngenta RNAi-based Biopesticides Sales by Product in 2024

12.2.6 Syngenta RNAi-based Biopesticides Sales by Application in 2024

12.2.7 Syngenta RNAi-based Biopesticides Sales by Geographic Area in 2024

12.2.8 Syngenta RNAi-based Biopesticides SWOT Analysis

12.2.9 Syngenta Recent Developments

12.3 Corteva

12.3.1 Corteva Corporation Information

12.3.2 Corteva Business Overview

12.3.3 Corteva RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.3.4 Corteva RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Corteva RNAi-based Biopesticides Sales by Product in 2024

12.3.6 Corteva RNAi-based Biopesticides Sales by Application in 2024

12.3.7 Corteva RNAi-based Biopesticides Sales by Geographic Area in 2024

12.3.8 Corteva RNAi-based Biopesticides SWOT Analysis

12.3.9 Corteva Recent Developments

12.4 BASF

12.4.1 BASF Corporation Information

12.4.2 BASF Business Overview

12.4.3 BASF RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.4.4 BASF RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 BASF RNAi-based Biopesticides Sales by Product in 2024

12.4.6 BASF RNAi-based Biopesticides Sales by Application in 2024

12.4.7 BASF RNAi-based Biopesticides Sales by Geographic Area in 2024

12.4.8 BASF RNAi-based Biopesticides SWOT Analysis

12.4.9 BASF Recent Developments

12.5 JR Simplot

12.5.1 JR Simplot Corporation Information

12.5.2 JR Simplot Business Overview

12.5.3 JR Simplot RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.5.4 JR Simplot RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 JR Simplot RNAi-based Biopesticides Sales by Product in 2024

12.5.6 JR Simplot RNAi-based Biopesticides Sales by Application in 2024

12.5.7 JR Simplot RNAi-based Biopesticides Sales by Geographic Area in 2024

12.5.8 JR Simplot RNAi-based Biopesticides SWOT Analysis

12.5.9 JR Simplot Recent Developments

12.6 Greenlight Biosciences

12.6.1 Greenlight Biosciences Corporation Information

12.6.2 Greenlight Biosciences Business Overview

12.6.3 Greenlight Biosciences RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.6.4 Greenlight Biosciences RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 Greenlight Biosciences Recent Developments

12.7 RNAissance Ag

12.7.1 RNAissance Ag Corporation Information

12.7.2 RNAissance Ag Business Overview

12.7.3 RNAissance Ag RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.7.4 RNAissance Ag RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.7.5 RNAissance Ag Recent Developments

12.8 Pebble Labs

12.8.1 Pebble Labs Corporation Information

12.8.2 Pebble Labs Business Overview

12.8.3 Pebble Labs RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.8.4 Pebble Labs RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.8.5 Pebble Labs Recent Developments

12.9 Renaissance BioScience

12.9.1 Renaissance BioScience Corporation Information

12.9.2 Renaissance BioScience Business Overview

12.9.3 Renaissance BioScience RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.9.4 Renaissance BioScience RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.9.5 Renaissance BioScience Recent Developments

12.10 AgroSpheres

12.10.1 AgroSpheres Corporation Information

12.10.2 AgroSpheres Business Overview

12.10.3 AgroSpheres RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.10.4 AgroSpheres RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.10.5 AgroSpheres Recent Developments

12.11 Silicon Gene

12.11.1 Silicon Gene Corporation Information

12.11.2 Silicon Gene Business Overview

12.11.3 Silicon Gene RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.11.4 Silicon Gene RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.11.5 Silicon Gene Recent Developments

12.12 Shanghai Plant Science Biotechnology

12.12.1 Shanghai Plant Science Biotechnology Corporation Information

12.12.2 Shanghai Plant Science Biotechnology Business Overview

12.12.3 Shanghai Plant Science Biotechnology RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.12.4 Shanghai Plant Science Biotechnology RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.12.5 Shanghai Plant Science Biotechnology Recent Developments

12.13 Xiaomo Biotech

12.13.1 Xiaomo Biotech Corporation Information

12.13.2 Xiaomo Biotech Business Overview

12.13.3 Xiaomo Biotech RNAi-based Biopesticides Product Models, Descriptions and Specifications

12.13.4 Xiaomo Biotech RNAi-based Biopesticides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.13.5 Xiaomo Biotech Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 RNAi-based Biopesticides Industry Chain

13.2 RNAi-based Biopesticides Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 RNAi-based Biopesticides Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 RNAi-based Biopesticides Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 RNAi-based Biopesticides Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global RNAi-based Biopesticides Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

FEATURED COMPANIES

Bayer

Syngenta AG

Corteva, Inc.

BASF AG

JR Simplot

Greenlight Biosciences

RNAissance Ag

Pebble Labs

Renaissance BioScience

AgroSpheres

Silicon Gene

Shanghai Plant Science Biotechnology

Xiaomo Biotech

List of Tables

Table 1. Global RNAi-based Biopesticides Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global RNAi-based Biopesticides Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global RNAi-based Biopesticides Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global RNAi-based Biopesticides Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global RNAi-based Biopesticides Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 7. Global RNAi-based Biopesticides Sales by Region (2020-2025) & (Tons)

Table 8. Global RNAi-based Biopesticides Sales by Region (2026-2031) & (Tons)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global RNAi-based Biopesticides Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)

Table 11. Global RNAi-based Biopesticides Production by Region (2020-2025) & (Tons)

Table 12. Global RNAi-based Biopesticides Production by Region (2026-2031) & (Tons)

Table 13. Global RNAi-based Biopesticides Sales by Manufacturers (2020-2025) & (Tons)

Table 14. Global RNAi-based Biopesticides Sales Share by Manufacturers (2020-2025)

Table 15. Global RNAi-based Biopesticides Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global RNAi-based Biopesticides Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global RNAi-based Biopesticides by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi-based Biopesticides as of 2024)

Table 19. Global RNAi-based Biopesticides Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global RNAi-based Biopesticides Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)

Table 21. Key Manufacturers RNAi-based Biopesticides Manufacturing Base and Headquarters

Table 22. Global RNAi-based Biopesticides Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global RNAi-based Biopesticides Sales by Type (2020-2025) & (Tons)

Table 26. Global RNAi-based Biopesticides Sales by Type (2026-2031) & (Tons)

Table 27. Global RNAi-based Biopesticides Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global RNAi-based Biopesticides Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global RNAi-based Biopesticides ASP by Type (2020-2031) & (US$/Ton)

Table 30. Technical Specifications by Key Product Type

Table 31. Global RNAi-based Biopesticides Sales by Application (2020-2025) & (Tons)

Table 32. Global RNAi-based Biopesticides Sales by Application (2026-2031) & (Tons)

Table 33. RNAi-based Biopesticides High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global RNAi-based Biopesticides Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global RNAi-based Biopesticides Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global RNAi-based Biopesticides ASP by Application (2020-2031) & (US$/Ton)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America RNAi-based Biopesticides Growth Accelerators and Market Barriers

Table 40. North America RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America RNAi-based Biopesticides Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 42. Europe RNAi-based Biopesticides Growth Accelerators and Market Barriers

Table 43. Europe RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe RNAi-based Biopesticides Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific RNAi-based Biopesticides Sales (Tons) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific RNAi-based Biopesticides Growth Accelerators and Market Barriers

Table 48. Southeast Asia RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America RNAi-based Biopesticides Investment Opportunities and Key Challenges

Table 50. Central and South America RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa RNAi-based Biopesticides Investment Opportunities and Key Challenges

Table 52. Middle East and Africa RNAi-based Biopesticides Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Bayer Corporation Information

Table 54. Bayer Description and Major Businesses

Table 55. Bayer Product Models, Descriptions and Specifications

Table 56. Bayer Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 57. Bayer Sales Value Proportion by Product in 2024

Table 58. Bayer Sales Value Proportion by Application in 2024

Table 59. Bayer Sales Value Proportion by Geographic Area in 2024

Table 60. Bayer RNAi-based Biopesticides SWOT Analysis

Table 61. Bayer Recent Developments

Table 62. Syngenta Corporation Information

Table 63. Syngenta Description and Major Businesses

Table 64. Syngenta Product Models, Descriptions and Specifications

Table 65. Syngenta Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 66. Syngenta Sales Value Proportion by Product in 2024

Table 67. Syngenta Sales Value Proportion by Application in 2024

Table 68. Syngenta Sales Value Proportion by Geographic Area in 2024

Table 69. Syngenta RNAi-based Biopesticides SWOT Analysis

Table 70. Syngenta Recent Developments

Table 71. Corteva Corporation Information

Table 72. Corteva Description and Major Businesses

Table 73. Corteva Product Models, Descriptions and Specifications

Table 74. Corteva Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 75. Corteva Sales Value Proportion by Product in 2024

Table 76. Corteva Sales Value Proportion by Application in 2024

Table 77. Corteva Sales Value Proportion by Geographic Area in 2024

Table 78. Corteva RNAi-based Biopesticides SWOT Analysis

Table 79. Corteva Recent Developments

Table 80. BASF Corporation Information

Table 81. BASF Description and Major Businesses

Table 82. BASF Product Models, Descriptions and Specifications

Table 83. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 84. BASF Sales Value Proportion by Product in 2024

Table 85. BASF Sales Value Proportion by Application in 2024

Table 86. BASF Sales Value Proportion by Geographic Area in 2024

Table 87. BASF RNAi-based Biopesticides SWOT Analysis

Table 88. BASF Recent Developments

Table 89. JR Simplot Corporation Information

Table 90. JR Simplot Description and Major Businesses

Table 91. JR Simplot Product Models, Descriptions and Specifications

Table 92. JR Simplot Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. JR Simplot Sales Value Proportion by Product in 2024

Table 94. JR Simplot Sales Value Proportion by Application in 2024

Table 95. JR Simplot Sales Value Proportion by Geographic Area in 2024

Table 96. JR Simplot RNAi-based Biopesticides SWOT Analysis

Table 97. JR Simplot Recent Developments

Table 98. Greenlight Biosciences Corporation Information

Table 99. Greenlight Biosciences Description and Major Businesses

Table 100. Greenlight Biosciences Product Models, Descriptions and Specifications

Table 101. Greenlight Biosciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 102. Greenlight Biosciences Recent Developments

Table 103. RNAissance Ag Corporation Information

Table 104. RNAissance Ag Description and Major Businesses

Table 105. RNAissance Ag Product Models, Descriptions and Specifications

Table 106. RNAissance Ag Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 107. RNAissance Ag Recent Developments

Table 108. Pebble Labs Corporation Information

Table 109. Pebble Labs Description and Major Businesses

Table 110. Pebble Labs Product Models, Descriptions and Specifications

Table 111. Pebble Labs Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 112. Pebble Labs Recent Developments

Table 113. Renaissance BioScience Corporation Information

Table 114. Renaissance BioScience Description and Major Businesses

Table 115. Renaissance BioScience Product Models, Descriptions and Specifications

Table 116. Renaissance BioScience Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 117. Renaissance BioScience Recent Developments

Table 118. AgroSpheres Corporation Information

Table 119. AgroSpheres Description and Major Businesses

Table 120. AgroSpheres Product Models, Descriptions and Specifications

Table 121. AgroSpheres Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 122. AgroSpheres Recent Developments

Table 123. Silicon Gene Corporation Information

Table 124. Silicon Gene Description and Major Businesses

Table 125. Silicon Gene Product Models, Descriptions and Specifications

Table 126. Silicon Gene Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 127. Silicon Gene Recent Developments

Table 128. Shanghai Plant Science Biotechnology Corporation Information

Table 129. Shanghai Plant Science Biotechnology Description and Major Businesses

Table 130. Shanghai Plant Science Biotechnology Product Models, Descriptions and Specifications

Table 131. Shanghai Plant Science Biotechnology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 132. Shanghai Plant Science Biotechnology Recent Developments

Table 133. Xiaomo Biotech Corporation Information

Table 134. Xiaomo Biotech Description and Major Businesses

Table 135. Xiaomo Biotech Product Models, Descriptions and Specifications

Table 136. Xiaomo Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 137. Xiaomo Biotech Recent Developments

Table 138. Key Raw Materials Distribution

Table 139. Raw Materials Key Suppliers

Table 140. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 141. Milestones in Production Technology Evolution

Table 142. Distributors List

Table 143. Market Trends and Market Evolution

Table 144. Market Drivers and Opportunities

Table 145. Market Challenges, Risks, and Restraints

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. RNAi-based Biopesticides Product Picture

Figure 2. Global RNAi-based Biopesticides Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. PIP Product Picture

Figure 4. Non-PIP Product Picture

Figure 5. Global RNAi-based Biopesticides Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Farmland

Figure 7. Orchard

Figure 8. Other

Figure 9. RNAi-based Biopesticides Report Years Considered

Figure 10. Global RNAi-based Biopesticides Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 12. Global RNAi-based Biopesticides Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global RNAi-based Biopesticides Revenue Market Share by Region (2020-2031)

Figure 14. Global RNAi-based Biopesticides Sales (2020-2031) & (Tons)

Figure 15. Global RNAi-based Biopesticides Sales (CAGR) by Region (2020-2031) (Tons)

Figure 16. Global RNAi-based Biopesticides Sales Market Share by Region (2020-2031)

Figure 17. Global RNAi-based Biopesticides Capacity, Production and Utilization (2020-2031) & (Tons)

Figure 18. Global RNAi-based Biopesticides Production Trend by Region (2020-2031) (Tons)

Figure 19. Global RNAi-based Biopesticides Production Market Share by Region (2020-2031)

Figure 20. Production Capacity Enablers & Constraints

Figure 21. RNAi-based Biopesticides Production Growth Rate in North America (2020-2031) & (Tons)

Figure 22. RNAi-based Biopesticides Production Growth Rate in Europe (2020-2031) & (Tons)

Figure 23. RNAi-based Biopesticides Production Growth Rate in China (2020-2031) & (Tons)

Figure 24. RNAi-based Biopesticides Production Growth Rate in Japan (2020-2031) & (Tons)

Figure 25. Top 5 and Top 10 Manufacturers RNAi-based Biopesticides Sales Volume Market Share in 2024

Figure 26. Global RNAi-based Biopesticides Revenue Market Share Ranking (2024)

Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 28. PIP Revenue Market Share by Manufacturer in 2024

Figure 29. Non-PIP Revenue Market Share by Manufacturer in 2024

Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 32. Global RNAi-based Biopesticides Sales Market Share by Type (2020-2031)

Figure 33. Global RNAi-based Biopesticides Revenue Market Share by Type (2020-2031)

Figure 34. Global RNAi-based Biopesticides Sales Market Share by Application (2020-2031)

Figure 35. Global RNAi-based Biopesticides Revenue Market Share by Application (2020-2031)

Figure 36. North America RNAi-based Biopesticides Sales YoY (2020-2031) & (Tons)

Figure 37. North America RNAi-based Biopesticides Revenue YoY (2020-2031) & (US$ Million)

Figure 38. North America Top 5 Manufacturers RNAi-based Biopesticides Sales Revenue (US$ Million) in 2024

Figure 39. North America RNAi-based Biopesticides Sales Volume (Tons) by Type (2020- 2031)

Figure 40. North America RNAi-based Biopesticides Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 41. North America RNAi-based Biopesticides Sales Volume (Tons) by Application (2020-2031)

Figure 42. North America RNAi-based Biopesticides Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. US RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 44. Canada RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 45. Mexico RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 46. Europe RNAi-based Biopesticides Sales YoY (2020-2031) & (Tons)

Figure 47. Europe RNAi-based Biopesticides Revenue YoY (2020-2031) & (US$ Million)

Figure 48. Europe Top 5 Manufacturers RNAi-based Biopesticides Sales Revenue (US$ Million) in 2024

Figure 49. Europe RNAi-based Biopesticides Sales Volume (Tons) by Type (2020-2031)

Figure 50. Europe RNAi-based Biopesticides Sales Revenue (US$ Million) by Type (2020-2031)

Figure 51. Europe RNAi-based Biopesticides Sales Volume (Tons) by Application (2020-2031)

Figure 52. Europe RNAi-based Biopesticides Sales Revenue (US$ Million) by Application (2020-2031)

Figure 53. Germany RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 54. France RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 55. U.K. RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 56. Italy RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 57. Russia RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 58. Asia-Pacific RNAi-based Biopesticides Sales YoY (2020-2031) & (Tons)

Figure 59. Asia-Pacific RNAi-based Biopesticides Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Asia-Pacific Top 8 Manufacturers RNAi-based Biopesticides Sales Revenue (US$ Million) in 2024

Figure 61. Asia-Pacific RNAi-based Biopesticides Sales Volume (Tons) by Type (2020- 2031)

Figure 62. Asia-Pacific RNAi-based Biopesticides Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 63. Asia-Pacific RNAi-based Biopesticides Sales Volume (Tons) by Application (2020-2031)

Figure 64. Asia-Pacific RNAi-based Biopesticides Sales Revenue (US$ Million) by Application (2020-2031)

Figure 65. Indonesia RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 66. Japan RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 67. South Korea RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 68. China Taiwan RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 69. India RNAi-based Biopesticides Revenue (2020-2031) & (US$ Million)

Figure 70. Central and South America RNAi-based Biopesticides Sales YoY (2020-2031) & (Tons)

Figure 71. Central and South America RNAi-based Biopesticides Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Central and South America Top 5 Manufacturers RNAi-based Biopesticides Sales Revenue (US$ Million) in 2024

Figure 73. Central and South America RNAi-based Biopesticides Sales Volume (Tons) by Type (2021-2031)

Figure 74. Central and South America RNAi-based Biopesticides Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Central and South America RNAi-based Biopesticides Sales Volume (Tons) by Application (2020-2031)

Figure 76. Central and South America RNAi-based Biopesticides Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. Brazil RNAi-based Biopesticides Revenue (2020-2025) & (US$ Million)

Figure 78. Argentina RNAi-based Biopesticides Revenue (2020-2025) & (US$ Million)

Figure 79. Middle East, and Africa RNAi-based Biopesticides Sales YoY (2020-2031) & (Tons)

Figure 80. Middle East and Africa RNAi-based Biopesticides Revenue YoY (2020-2031) & (US$ Million)

Figure 81. Middle East and Africa Top 5 Manufacturers RNAi-based Biopesticides Sales Revenue (US$ Million) in 2024

Figure 82. Middle East and Africa RNAi-based Biopesticides Sales Volume (Tons) by Type (2021-2031)

Figure 83. South America RNAi-based Biopesticides Sales Revenue (US$ Million) by Type (2020-2031)

Figure 84. Middle East and Africa RNAi-based Biopesticides Sales Volume (Tons) by Application (2020-2031)

Figure 85. Middle East and Africa RNAi-based Biopesticides Sales Revenue (US$ Million) by Application (2020-2031)

Figure 86. GCC Countries RNAi-based Biopesticides Revenue (2020-2025) & (US$ Million)

Figure 87. Turkey RNAi-based Biopesticides Revenue (2020-2025) & (US$ Million)

Figure 88. Egypt RNAi-based Biopesticides Revenue (2020-2025) & (US$ Million)

Figure 89. South Africa RNAi-based Biopesticides Revenue (2020-2025) & (US$ Million)

Figure 90. RNAi-based Biopesticides Industry Chain Mapping

Figure 91. Regional RNAi-based Biopesticides Manufacturing Base Distribution (%)

Figure 92. RNAi-based Biopesticides Production Process

Figure 93. Regional RNAi-based Biopesticides Production Cost Structure

Figure 94. Channels of Distribution (Direct Vs Distribution)

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global RNA Interference Biopesticides Market Research Report 2024

Global RNAi Biopesticides Market Research Report 2024

Global RNA Biopesticide Market Research Report 2025

Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Biopesticide Preparations Market Research Report 2024

Global Biopesticide Market Research Report 2024

Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biological Pesticide Market Research Report 2024

Global Biogenic Pesticide Market Insights Forecast to 2030

Global RNAi Therapeutics Market Research Report 2024

Global Fungi based Biopesticides Market Research Report 2024

Global Agricultural Biopesticides Market Research Report 2025

Global Bio Rational Pesticides Market Research Report 2025

Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024

RNAi Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Fungal Based Biopesticide Market Research Report 2024

RNAi Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vector Based RNAi Market Research Report 2024

Global Small Interfering RNA siRNA Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions